Evaluation of drug efficacy in a rodent model of neuropathic pain
Ended Purchase Order Awarded Last action
- Contract number
- 75N95021P00580
- Awardee
-
PGI Holding Corporation UEI WZ4JEKPZXJ87
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $216,900
Award facts
- Opportunity
-
- Evaluation of Drug Efficacy in a Rat Model of Neuropathic Pain Pre-Solicitation · 75N95021Q00118 · Posted Apr 6, 2021
- Evaluation of Drug Efficacy in a Rodent Model of Neuropathic Pain Solicitation · Posted Jul 27, 2021
- Contract value 100% obligated
- $216,900.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Paramus, NJ 07652, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $35,800 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $181,100 |
About this award
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to PGI Holding Corporation, a for-profit subchapter S corporation, to evaluate the efficacy of a nanoparticle formulation containing the drug aprepitant in a rodent model of neuropathic pain. The contract, valued at $216,900.00, has a period of performance from September 20, 2021 to March 31, 2023. The work involves conducting a mouse spinal nerve spared (SNS) model of neuropathic pain, administering the nanoparticle and free drug formulations intrathecally, and evaluating mechanical allodynia using von Frey hairs. This contract is not designated as a small business set-aside.
Quick answers
Who was awarded contract 75N95021P00580?
75N95021P00580 was awarded to PGI Holding Corporation by National Institute on Drug Abuse (National Institutes of Health) on September 20, 2021.
How much is contract 75N95021P00580 worth?
The government has obligated $216,900 on 75N95021P00580.
Which agency awarded contract 75N95021P00580?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95021P00580, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95021P00580 competed?
The extent of competition for 75N95021P00580 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award